Skip to content
Search

Latest Stories

Minor ailments cause many to miss work: Pharmacist busts myths about UTIs, sore throats

Minor ailments cause many to miss work: Pharmacist busts myths about UTIs, sore throats

A new NPA poll reveals that 36% of people were unaware of the Pharmacy First service, which allow pharmacies to treat 7 common minor ailments

The National Pharmacy Association (NPA) is encouraging individuals to visit their local pharmacy for the treatment of minor ailments to avoid unnecessary days off from work, save the NHS money and improve patient care.

A new NPA poll revealed that 55 per cent of workers missed at least one day of work last year due to coughs, colds, and other minor illnesses.


The survey, which involved over 2,000 patients and was conducted by Research without Barriers, found that 31 per cent of respondents were absent from work for 1-6 days, 15 per cent for a week, 12 per cent for two weeks and 3 per cent for three weeks.

This polling is part of the NPA’s Ask Your Pharmacist Week campaign, which aims to dispel common myths around minor ailments and encourage greater use of local pharmacies for medical treatment.

In England, pharmacies can now provide NHS treatments for a range of common ailments through the Pharmacy First Service, including ear infections, impetigo, shingles, sinusitis, sore throat, infected insect bites and uncomplicated urinary tract infections (UTIs).

However, 36 per cent of people surveyed were unaware of the Pharmacy First service, with 20 per cent believing such ailments could only be treated by their GP.

Sukhi Basra, pharmacist and board member of the NPA, said: “It is concerning that a large number of people have to miss work for illnesses that could be promptly treated and prevented by their local pharmacist as well as not being aware of the wide range of services offered in their pharmacies.”

As winter approaches, Basra warned of an ‘inevitable’ surge in minor illnesses.

She emphasised that pharmacies are one of the most accessible parts of the health care system, providing high-quality health care on people’s doorsteps.

“Services like NHS Pharmacy First offer same day help for common ailments, saving time for both patients and GPs.

“By debunking myths and making healthcare more accessible, pharmacists are ensuring that people can confidently manage their health this winter and beyond,” she added.

Myths about UTIs, sore throats and other minor ailments busted 

The NPA poll also found that a third (32 per cent) of patients believe that all UTIs will resolve on their own.

Thorrun Govind, a pharmacist and TV health expert, addressed this misconception stating, “While some mild UTIs may resolve without treatment, some may require antibiotics to prevent complications such as kidney infections.”

Additionally, 40 per cent of patients believe that the flu vaccine can cause the flu, with 13 per cent saying it definitely could and 27 per cent saying it sometimes could.

The former chair of Royal Pharmaceutical Society (RPS) clarified: “The flu vaccine contains inactivated (killed) viruses or a single protein from the flu virus. Some people might experience mild side effects like a low-grade fever or muscle aches.”

Moreover, 22 per cent of patients believed that all sore throats can be treated by antibiotics, and 11 per cent thought the same for athlete’s foot.

Busting these myths, Thorrun explained: “Most sore throats are caused by viruses, not bacteria, and antibiotics are ineffective against viral infections.

“Athlete’s foot is a fungal infection and requires antifungal treatment, not antibiotics which are used to treat bacterial infections.”

Ask Your Pharmacist Week, a joint initiative between the NPA and NHS England, runs from November 4 to November 11.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less